254 related articles for article (PubMed ID: 7698167)
21. Cardiovascular effects of the novel potassium channel opener UR-8225.
Tamargo J; Pérez O; Delpón E; García-Rafanell J; Gómez L; Cavalcanti F
J Cardiovasc Pharmacol; 1995 Aug; 26(2):295-305. PubMed ID: 7475055
[TBL] [Abstract][Full Text] [Related]
22. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
23. Regional hemodynamic dose-response of lemakalim and glybenclamide in anesthetized rats.
Smits GJ; Perrone MH; Cox BF
J Cardiovasc Pharmacol; 1997 Jan; 29(1):49-56. PubMed ID: 9007670
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular pharmacological studies on JTV-506, a new potassium channel opener. 1st communication: effects on myocardium and vasculature.
Hirata Y; Suzuki Y; Miyai H; Aisaka K
Arzneimittelforschung; 2000 Mar; 50(3):236-43. PubMed ID: 10758774
[TBL] [Abstract][Full Text] [Related]
25. KATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats.
Baczkó I; Leprán I; Papp JG
Eur J Pharmacol; 1997 Apr; 324(1):77-83. PubMed ID: 9137916
[TBL] [Abstract][Full Text] [Related]
26. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia.
Nakae I; Quan L; Sugimoto Y; Tsutamoto T; Kinoshita M
J Cardiovasc Pharmacol; 1994 Mar; 23(3):473-9. PubMed ID: 7515993
[TBL] [Abstract][Full Text] [Related]
27. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
Yamada H; Yoneyama F; Satoh K; Taira N
Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular responses to glibenclamide during endotoxaemia in the pig.
Vanelli G; Hussain SN; Dimori M; Aguggini G
Vet Res Commun; 1997 Apr; 21(3):187-200. PubMed ID: 9090046
[TBL] [Abstract][Full Text] [Related]
29. Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state.
Seki S; Sato K; Nakayama M; Murray PA
Anesthesiology; 1997 Apr; 86(4):923-35. PubMed ID: 9105237
[TBL] [Abstract][Full Text] [Related]
30. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
31. Relaxant effects of cromakalim and ATP depletion in dog and rat mesenteric arteries--species differences.
Hong KW; Rhim BY; Kim CD; Yoo SE
Arch Int Pharmacodyn Ther; 1994; 328(1):54-66. PubMed ID: 7893191
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of action of KRN2391, a novel vasodilator, in canine mesenteric artery.
Ogawa N; Fukata Y; Kaneta S; Jinno Y; Miwa A; Fukushima H
Jpn J Pharmacol; 1993 Apr; 61(4):303-9. PubMed ID: 8320876
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of action of KRN2391 in canine coronary vascular bed.
Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
[TBL] [Abstract][Full Text] [Related]
34. Beta 2-adrenergic dilation of resistance coronary vessels involves KATP channels and nitric oxide in conscious dogs.
Ming Z; Parent R; Lavallée M
Circulation; 1997 Mar; 95(6):1568-76. PubMed ID: 9118527
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery.
Eckman DM; Frankovich JD; Keef KD
Br J Pharmacol; 1992 May; 106(1):9-16. PubMed ID: 1504734
[TBL] [Abstract][Full Text] [Related]
36. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim.
Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M
J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008
[TBL] [Abstract][Full Text] [Related]
37. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
Yao Z; Gross GJ
Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
[TBL] [Abstract][Full Text] [Related]
38. Lemakalim attenuates hypocapnia- and dry air-induced bronchoconstriction in canine peripheral airways.
Lindeman KS; Freed AN
J Appl Physiol (1985); 1993 Jul; 75(1):86-92. PubMed ID: 8376305
[TBL] [Abstract][Full Text] [Related]
39. Comparison of coronary dilating effects of Ki1769, a new K channel opener of the pyridinecarboximidamide type, and nifedipine in anesthetized dogs.
Yokoyama T; Kaneta S; Miwa A; Tanaka Y; Izumi H; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):194-203. PubMed ID: 7979828
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotective effects of YM934, an ATP-sensitive potassium channel opener, on stunned myocardium in anesthetized dogs.
Taguchi T; Uchida W; Takenaka T; Takeo S
Gen Pharmacol; 1999 Jun; 32(6):695-703. PubMed ID: 10401995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
